Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$350,986
+$92,613 QoQ
Shares Held
1,382
+30.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#4,023
of 4,664 holders
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Quarry LP holds $1,233,687 across 11 Drug Manufacturers - General names. JNJ ranks #1 (28.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
1,382 | $350,986 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
2,631 | $332,400 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
5,660 | $326,129 | |
| 4 | OGN |
Organon & Co.
|
9,891 | $133,924 | |
| 5 | LLY |
ELI LILLY & Co
|
40 | $47,977 | |
| 6 | AZN |
Astrazeneca PLC
|
165 | $31,287 | |
| 7 | PFE |
Pfizer Inc
|
227 | $5,466 | |
| 8 | ABBV |
AbbVie Inc.
|
11 | $2,768 |
All Filings in JNJ
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $350,986 | 1,382 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $258,373 | 1,057 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $376,028 | 1,817 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $8,343 | 45 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $347,659 | 2,276 | Shares | Other | 2025-08-14 | |
| 2024-12-31 | $458,590 | 3,171 | Shares | Other | 2025-02-14 | |
| 2024-06-30 | $48,963 | 335 | Shares | Other | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||